Releasing Alogliptin

Within the series of parties held by Hama Pharma to release “Alogliptin Hama Pharma”, the newest medicene from its blood sugar-lowering group, Hama Pharma had the honor to invite endocrinologists, internal and cardiologists in Damascus for a lecture entitled:
Treating diabetes type II review of the DPP_4i group
For the lecturer: Dr. Zuhair Fedda, an endocrinologist from Lattakia Governorate.
This was followed by an introduction to the most important features of Alogliptin in terms of selectivity, effectiveness and safety, presented by the pharmacist: Hiba Rabie, Manager of the Scientific Office of Hama Pharma.
All thanks to the doctors for their attendance and response, with our best wishes for a cure for all patients.